Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

However, this treatment is not always effective in some patients. Now scientists have investigated a different antibody type, IgE, which activates the patient's immune system in different ways to IgG.

Tumours, such as some breast and ovarian cancers, can express the marker HER2. HER2 is responsible for cancer growth and is the target of existing therapies, such as the most commonly used type of ...

Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...